Oak Ridge Investments’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-126,221
Closed -$1.65M 155
2024
Q1
$1.65M Buy
126,221
+12,914
+11% +$172K 0.17% 103
2023
Q4
$1.44M Buy
113,307
+24,642
+28% +$249K 0.17% 107
2023
Q3
$1.16M Sell
88,665
-4,076
-4% -$74.6K 0.15% 110
2023
Q2
$2.37M Sell
92,741
-2,992
-3% -$77.2K 0.29% 95
2023
Q1
$2.41M Buy
+95,733
New +$2.25M 0.33% 92

Other funds holding TMCI

Oak Ridge Investments's TMCI Position: Q2 2024 in Review

Oak Ridge Investments sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 126,221 shares — an estimated $1.65M sold.

Oak Ridge Investments first reported a position in TMCI in Q1 2023 and held it in 5 quarters. The position peaked at $2.41M in Q1 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Oak Ridge Investments reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Oak Ridge Investments sold 126,221 Treace Medical Concepts shares in Q2 2024, an estimated $1.65M.
  • Oak Ridge Investments first reported a position in Treace Medical Concepts in Q1 2023 and held it in 5 quarters.
  • Oak Ridge Investments's Treace Medical Concepts position peaked at $2.41M in Q1 2023.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Oak Ridge Investments's 13F filing for Q2 2024, filed 16 Jul 2024.